Category: ACT-AD (Accelerate Cure/Treatments for Alzheimer’s Disease) (Page 2)

November 16, 2016

Experts Explore Federal Agency Collaborations to Close Alzheimer’s Disease Research Gaps at ACT-AD Coalition Annual Meeting

Today, senior representatives from the U.S. Food and Drug Administration (FDA) and the National Institute on Aging at the National Institutes of Health (NIH) joined with advocates, federal colleagues, researchers, and industry to explore collaborations for advancing the most up-to-date knowledge in Alzheimer’s disease research. 
November 16, 2016

9th Annual FDA/Alzheimer’s Disease Allies Meeting

The ACT-AD Coalition will hold its 9th Annual FDA/Alzheimer’s Disease Allies Meeting on Wednesday, November 16, 2016 at the Bethesda North Marriott Hotel & Conference Center. 
October 31, 2016

ACT-AD Will Host Ninth Annual Meeting

The ACT-AD Coalition will host its Ninth Annual FDA/Alzheimer's Disease Allies Meeting on November 16, 2016. 
August 23, 2016

Alliance Comments on PDUFA VI Commitment Letter

The Alliance provided comments in response to the U.S. Food and Drug Administration's PDUFA VI Commitment Letter.
July 25, 2016

ACT-AD Holds Webinar on Clinical Meaningfulness in Alzheimer’s Disease

On July 19, 2016, the ACT-AD Coalition presented an one-hour webinar on clinical meaningfulness in Alzheimer’s disease.
June 24, 2016

Alliance’s Bens Speaks at Capitol Hill Briefing on Precision Medicine

On Wednesday, the Alliance’s Vice President of Public Policy Cynthia Bens spoke at a Congressional Life Sciences Caucus briefing about precision medicine on Capitol Hill.
May 13, 2016

We Bring People and Organizations Together to Advance Science

A major way the Alliance advances science is through building coalitions of diverse organizations and individuals to bring visibility and support to health research, with the ultimate goal of improving the healthy length and quality of life for everyone. Learn more. 
February 8, 2016

Alzheimer’s Disease and Personalized Medicine Webinar/February 29

On February 29, the ACT-AD coalition holds a webinar about Alzheimer's disease and personalized medicine. 
January 21, 2016

Study Looks at Alzheimer’s Potential Impact on China

A new study discusses the potential long-term impacts China could face from Alzheimer's disease.
November 30, 2015

New Enewsletters on Alzheimer’s Disease and Healthspan Now Available

This is a quick post to give you a heads up that the latest editions of the ACT-AD Coalition and Healthspan Campaign enewsletters are now available.